Showing results (71-80 of 88) with videos related to
Sort By:
Pageof 9
Journal of Hepatology|April 10, 2019
Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategiesGilles Wandeler, Etienne Mauron, Andrew Atkinson, et al.Plos One|February 28, 2019
Provir/Latitude 45 study: A step towards a multi-epitopic CTL vaccine designed on archived HIV-1 DNA and according to dominant HLA I allelesCamille Tumiotto, Bruna M Alves, Patricia Recordon-Pinson, et al.Open Forum Infectious Diseases|September 19, 2024
Epidemiology of <i>Campylobacter</i> Species Infection in Kidney Transplant Recipients: A Retrospective Multicentric Case-Control Study in FranceFeline Bos, Romain Gueneau, Thomas Crepin, et al.AIDS (London, England)|May 18, 2023
Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiationMathieu Chalouni, Adam Trickey, Suzanne M Ingle, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2014
Telaprevir for HIV/hepatitis C virus-coinfected patients failing treatment with pegylated interferon/ribavirin (ANRS HC26 TelapreVIH): an open-label, single-arm, phase 2 trialLaurent Cotte, Joséphine Braun, Caroline Lascoux-Combe, et al.European Journal of Gastroenterology & Hepatology|April 30, 2019
Liver stiffness and fibrosis-4 alone better predict liver events compared with aspartate aminotransferase to platelet ratio index in a cohort of human immunodeficiency virus and hepatitis C virus co-infected patients from ANRS CO13 HEPAVIH cohortMathieu Chalouni, Philippe Sogni, Patrick Miailhes, et al.Open Forum Infectious Diseases|December 14, 2019
Corrigendum to: Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.Open Forum Infectious Diseases|October 30, 2019
Impact of the M184V/I Mutation on the Efficacy of Abacavir/Lamivudine/Dolutegravir Therapy in HIV Treatment-Experienced PatientsFlaminia Olearo, Huyen Nguyen, Fabrice Bonnet, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 8, 2015
Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort CollaborationMargaret T May, Amy C Justice, Kate Birnie, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 6, 2022
Retrospective Multicenter Study Comparing Infectious and Noninfectious AortitisMathilde Carrer, Carole Vignals, Xavier Berard, et al.Pageof 9